Matches in SemOpenAlex for { <https://semopenalex.org/work/W2995188001> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2995188001 endingPage "S749" @default.
- W2995188001 startingPage "S749" @default.
- W2995188001 abstract "Motor-related symptoms of patients with Parkinson's disease (PD) are caused by the decrease of dopamine (DA) in the midbrain. Decrease in DA induces imbalance between DA and acetylcholine (ACh), leading to an increase in the relative Ach level, which in turn contributes to motor symptoms again. Therefore, administration of acetylcholinesterase inhibitor (ACHEI), which inhibits the degradation of ACh, to PD patients should be avoided as it may exacerbate the imbalance between DA and Ach. However, a lot of PD patients are using ACHEI for the treatment of cognitive symptoms. Thus, we aimed to analyze the actual use of ACHEI in elderly patients with PD in Korea. PD patients were defined as those having at least one claim record with a diagnosis of PD (ICD-10 codes: G20-21) from 2016 Health Insurance Review and Assessment Service (HIRA) - Adult Patients Sample (APS) data, composed of 20% random sample of patient aged 65 and over in Korea. ACHEI users were defined as those with at least one prescription record of donepezil, rivastigmine or galantamine. Demographic characteristics were compared between ACHEI users and non-users. Of 24,524 PD patients identified from the 2016 HIRA-APS data, 8,928 patients (36%) were ACHEI users. ACHEI use increased with age (25% in 65-74, 42% in 75-84, and 49% in 85 and over, p <0.0001). The use of ACHEI was more common in women (38%) than men (34%, p <0.0001). Medical Aid beneficiaries (40%) tended to use ACHEI more than National Health Insurance beneficiaries (36%, p <0.0001). The use of ACHEI among PD patients in Korea is high. In-depth analysis should be conducted to identify factors affecting ACHEI prescribing in PD patients and to establish effective strategy to avoid potentially inappropriate use of ACHEI at clinical and the national level." @default.
- W2995188001 created "2019-12-26" @default.
- W2995188001 creator A5034116139 @default.
- W2995188001 creator A5049421316 @default.
- W2995188001 date "2019-11-01" @default.
- W2995188001 modified "2023-10-17" @default.
- W2995188001 title "PND66 ASSESSING THE POTENTIALLY INAPPROPRIATE USE OF ACETYLCHOLINESTERASE INHIBITORS IN ELDERLY PATIENTS WITH PARKINSON DISEASE USING KOREA NATIONAL HEALTH INSURANCE CLAIMS DATA" @default.
- W2995188001 doi "https://doi.org/10.1016/j.jval.2019.09.1836" @default.
- W2995188001 hasPublicationYear "2019" @default.
- W2995188001 type Work @default.
- W2995188001 sameAs 2995188001 @default.
- W2995188001 citedByCount "0" @default.
- W2995188001 crossrefType "journal-article" @default.
- W2995188001 hasAuthorship W2995188001A5034116139 @default.
- W2995188001 hasAuthorship W2995188001A5049421316 @default.
- W2995188001 hasBestOaLocation W29951880011 @default.
- W2995188001 hasConcept C126322002 @default.
- W2995188001 hasConcept C181199279 @default.
- W2995188001 hasConcept C185592680 @default.
- W2995188001 hasConcept C2426938 @default.
- W2995188001 hasConcept C2776332859 @default.
- W2995188001 hasConcept C2778816929 @default.
- W2995188001 hasConcept C2779056891 @default.
- W2995188001 hasConcept C2779134260 @default.
- W2995188001 hasConcept C2779483572 @default.
- W2995188001 hasConcept C2780904820 @default.
- W2995188001 hasConcept C55493867 @default.
- W2995188001 hasConcept C71924100 @default.
- W2995188001 hasConcept C98274493 @default.
- W2995188001 hasConceptScore W2995188001C126322002 @default.
- W2995188001 hasConceptScore W2995188001C181199279 @default.
- W2995188001 hasConceptScore W2995188001C185592680 @default.
- W2995188001 hasConceptScore W2995188001C2426938 @default.
- W2995188001 hasConceptScore W2995188001C2776332859 @default.
- W2995188001 hasConceptScore W2995188001C2778816929 @default.
- W2995188001 hasConceptScore W2995188001C2779056891 @default.
- W2995188001 hasConceptScore W2995188001C2779134260 @default.
- W2995188001 hasConceptScore W2995188001C2779483572 @default.
- W2995188001 hasConceptScore W2995188001C2780904820 @default.
- W2995188001 hasConceptScore W2995188001C55493867 @default.
- W2995188001 hasConceptScore W2995188001C71924100 @default.
- W2995188001 hasConceptScore W2995188001C98274493 @default.
- W2995188001 hasLocation W29951880011 @default.
- W2995188001 hasOpenAccess W2995188001 @default.
- W2995188001 hasPrimaryLocation W29951880011 @default.
- W2995188001 hasRelatedWork W2017645489 @default.
- W2995188001 hasRelatedWork W2118420513 @default.
- W2995188001 hasRelatedWork W2136995362 @default.
- W2995188001 hasRelatedWork W2410808262 @default.
- W2995188001 hasRelatedWork W2419006579 @default.
- W2995188001 hasRelatedWork W2769446265 @default.
- W2995188001 hasRelatedWork W2980147368 @default.
- W2995188001 hasRelatedWork W3153101125 @default.
- W2995188001 hasRelatedWork W4233796751 @default.
- W2995188001 hasRelatedWork W4312725223 @default.
- W2995188001 hasVolume "22" @default.
- W2995188001 isParatext "false" @default.
- W2995188001 isRetracted "false" @default.
- W2995188001 magId "2995188001" @default.
- W2995188001 workType "article" @default.